These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 34655285)

  • 41. Mechano-transduction in osteoblastic cells involves strain-regulated estrogen receptor alpha-mediated control of insulin-like growth factor (IGF) I receptor sensitivity to Ambient IGF, leading to phosphatidylinositol 3-kinase/AKT-dependent Wnt/LRP5 receptor-independent activation of beta-catenin signaling.
    Sunters A; Armstrong VJ; Zaman G; Kypta RM; Kawano Y; Lanyon LE; Price JS
    J Biol Chem; 2010 Mar; 285(12):8743-58. PubMed ID: 20042609
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combination of tanshinone IIA and astragaloside IV attenuate atherosclerotic plaque vulnerability in ApoE(-/-) mice by activating PI3K/AKT signaling and suppressing TRL4/NF-κB signaling.
    Wang N; Zhang X; Ma Z; Niu J; Ma S; Wenjie W; Chen J
    Biomed Pharmacother; 2020 Mar; 123():109729. PubMed ID: 31887543
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activation of Akt/GSK-3beta signaling pathway is involved in intermedin(1-53) protection against myocardial apoptosis induced by ischemia/reperfusion.
    Song JQ; Teng X; Cai Y; Tang CS; Qi YF
    Apoptosis; 2009 Sep; 14(9):1061-9. PubMed ID: 19634012
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of phosphatidylinositol 3-kinase-Akt signaling blocks growth, promotes apoptosis, and enhances sensitivity of small cell lung cancer cells to chemotherapy.
    Krystal GW; Sulanke G; Litz J
    Mol Cancer Ther; 2002 Sep; 1(11):913-22. PubMed ID: 12481412
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tanshinone IIA protects against myocardial ischemia reperfusion injury by activating the PI3K/Akt/mTOR signaling pathway.
    Li Q; Shen L; Wang Z; Jiang HP; Liu LX
    Biomed Pharmacother; 2016 Dec; 84():106-114. PubMed ID: 27643552
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Insulin-like growth factor-I inhibits transcriptional responses of transforming growth factor-beta by phosphatidylinositol 3-kinase/Akt-dependent suppression of the activation of Smad3 but not Smad2.
    Song K; Cornelius SC; Reiss M; Danielpour D
    J Biol Chem; 2003 Oct; 278(40):38342-51. PubMed ID: 12876289
    [TBL] [Abstract][Full Text] [Related]  

  • 47. TanshinoneⅡA inhibits excessive autophagy and protects myocardium against ischemia/reperfusion injury via 14-3-3η/Akt/Beclin1 pathway.
    Wen L; Cheng X; Fan Q; Chen Z; Luo Z; Xu T; He M; He H
    Eur J Pharmacol; 2023 Sep; 954():175865. PubMed ID: 37406848
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A network-based method for mechanistic investigation and neuroprotective effect on treatment of tanshinone Ⅰ against ischemic stroke in mouse.
    Liu J; Wang F; Sheng P; Xia Z; Jiang Y; Yan BC
    J Ethnopharmacol; 2021 May; 272():113923. PubMed ID: 33617968
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Tanshinone IIA inhibits cardiomyocyte apoptosis and rescues cardiac function during doxorubicin-induced cardiotoxicity by activating the DAXX/MEK/ERK1/2 pathway.
    Xu L; He D; Wu Y; Shen L; Wang Y; Xu Y
    Phytomedicine; 2022 Dec; 107():154471. PubMed ID: 36182795
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protective effect of Tanshinone IIA against infarct size and increased HMGB1, NFκB, GFAP and apoptosis consequent to transient middle cerebral artery occlusion.
    Wang JG; Bondy SC; Zhou L; Yang FZ; Ding ZG; Hu Y; Tian Y; Wen PY; Luo H; Wang F; Li WW; Zhou J
    Neurochem Res; 2014 Feb; 39(2):295-304. PubMed ID: 24362639
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tanshinone IIA induces mitochondria dependent apoptosis in prostate cancer cells in association with an inhibition of phosphoinositide 3-kinase/AKT pathway.
    Won SH; Lee HJ; Jeong SJ; Lee HJ; Lee EO; Jung DB; Shin JM; Kwon TR; Yun SM; Lee MH; Choi SH; Lü J; Kim SH
    Biol Pharm Bull; 2010; 33(11):1828-34. PubMed ID: 21048307
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer.
    Cui X; Zhang P; Deng W; Oesterreich S; Lu Y; Mills GB; Lee AV
    Mol Endocrinol; 2003 Apr; 17(4):575-88. PubMed ID: 12554765
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Carthamus tinctorius L. extract activates insulin-like growth factor-I receptor signaling to inhibit FAS-death receptor pathway and suppress lipopolysaccharides-induced H9c2 cardiomyoblast cell apoptosis.
    Tung CL; Ju DT; Velmurugan BK; Ban B; Dung TD; Hsieh DJ; P Viswanadha V; Day CH; Lin YM; Huang CY
    Environ Toxicol; 2019 Dec; 34(12):1320-1328. PubMed ID: 31486215
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tanshinone IIA alleviates blast-induced inflammation, oxidative stress and apoptosis in mice partly by inhibiting the PI3K/Akt/FoxO1 signaling pathway.
    Liu Y; Tong C; Tang Y; Cong P; Liu Y; Shi X; Shi L; Zhao Y; Jin H; Li J; Hou M
    Free Radic Biol Med; 2020 May; 152():52-60. PubMed ID: 32131025
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protective effect of proanthocyanidins on anoxia-reoxygenation injury of myocardial cells mediated by the PI3K/Akt/GSK-3β pathway and mitochondrial ATP-sensitive potassium channel.
    Hu Y; Li L; Yin W; Shen L; You B; Gao H
    Mol Med Rep; 2014 Oct; 10(4):2051-8. PubMed ID: 25109283
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cardioprotective effect of Danshensu against myocardial ischemia/reperfusion injury and inhibits apoptosis of H9c2 cardiomyocytes via Akt and ERK1/2 phosphorylation.
    Yin Y; Guan Y; Duan J; Wei G; Zhu Y; Quan W; Guo C; Zhou D; Wang Y; Xi M; Wen A
    Eur J Pharmacol; 2013 Jan; 699(1-3):219-26. PubMed ID: 23200898
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phytoestrogen, tanshinone IIA diminishes collagen deposition and stimulates new elastogenesis in cultures of human cardiac fibroblasts.
    Mao S; Wang Y; Zhang M; Hinek A
    Exp Cell Res; 2014 Apr; 323(1):189-197. PubMed ID: 24525372
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tanshinone IIA combined with cisplatin synergistically inhibits non-small-cell lung cancer in vitro and in vivo via down-regulating the phosphatidylinositol 3-kinase/Akt signalling pathway.
    Liao XZ; Gao Y; Huang S; Chen ZZ; Sun LL; Liu JH; Chen HR; Yu L; Zhang JX; Lin LZ
    Phytother Res; 2019 Sep; 33(9):2298-2309. PubMed ID: 31268205
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tanshinone IIA protects neonatal rat cardiomyocytes from adriamycin-induced apoptosis.
    Gao J; Yang G; Pi R; Li R; Wang P; Zhang H; Le K; Chen S; Liu P
    Transl Res; 2008 Feb; 151(2):79-87. PubMed ID: 18201675
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Short-term hypoxia upregulated Mas receptor expression to repress the AT
    Chang RL; Chang CF; Ju DT; Ho TJ; Chang TT; Lin JW; Li JC; Cheng SM; Day CH; Viswanadha VP; Huang CY
    J Cell Biochem; 2018 Mar; 119(3):2742-2749. PubMed ID: 29052864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.